Next generation quality control for cell therapy
Stem Genomics provides dedicated services to assess the genetic integrity of human stem cells. We help research scientists with specific assays and recommended workflows for the cell type they work with. Our flagship testing solution, iCS-digitalTM PSC, has revolutionized in-process genomic stability testing in hPSCs thanks to its high precision, ease and speed. It is particularly interesting for regularly monitoring stem cell lines in culture as well as for screening large numbers of clones, e.g., CRISPR-edited clones or human iPSC clones after reprogramming. We can also perform the following tests for you: G-Banding karyotyping, NGS analysis, mycoplasma detection, aneuploidy detection, or design customized assays to meet your requirements.
digital PCR, Next Generation Sequencing, and Karyotyping
Next generation quality control for cell therapy
Stem Genomics provides dedicated services to assess the genetic integrity of human stem cells. We help research scientists with specific assays and recommended workflows for the cell type they work with. Our flagship testing solution, iCS-digitalTM PSC, has revolutionized in-process genomic stability testing in hPSCs thanks to its high precision, ease and speed. It is particularly interesting for regularly monitoring stem cell lines in culture as well as for screening large numbers of clones, e.g., CRISPR-edited clones or human iPSC clones after reprogramming. We can also perform the following tests for you: G-Banding karyotyping, NGS analysis, mycoplasma detection, aneuploidy detection, or design customized assays to meet your requirements.
Stem Genomics offers fast iPSC quality control, cost-effective solutions for stem cell characterization. G-Banding karyotyping, detect CNV, mycoplasma, aneuploidy...
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Institut du Cerveau – Paris Brain Institute Startup accelerator & VC, Biotechnology Research | Institut du Cerveau – Paris Brain Institute Startup accelerator & VC, Biotechnology Research | Other 22 Jun 2023 | | |
BIC de Montpellier Government Administration | BIC de Montpellier Government Administration | Not capitalistic Not partnership Event 9 Nov 2018 | |